In drug-resistant nasopharyngeal carcinoma cells, the m6A modification of TRIM11 mediated by METTL3 promotes the stability of TRIM11 mRNA through the m6A-IGF2BP2-dependent pathway, which partially increases the expression of the TRIM11 protein. Here, TRIM11 is linked to nasopharyngeal carcinoma.